TAMPA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), today applauds the historic federal action directing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, a landmark policy shift that formally recognizes cannabis's accepted medical use and represents a critical step toward a more rational and regulated national cannabis framework.
"Federal rescheduling is a pivotal moment for patients, operators, and investors," said David Vautrin, Interim CEO of FLUENT. "We applaud the Administration for recognizing the therapeutic benefits of cannabis-based medicine and advancing common-sense reforms, including 280E relief."
Schedule III status will reduce federal policy barriers, improve access to banking, and allow companies to deduct ordinary business expenses previously disallowed under 280E, freeing capital for patient care, product innovation, and market expansion.
This rescheduling follows recent federal clarification around hemp-derived intoxicants passed on November 12th, 2025. This action materially shuts down the depth and reach of intoxicating hemp derived Cannabis by November 2026. This is expected to reduce unlicensed competition and ease pricing pressure enterprise wide with the greatest impact in key FLUENT states such as Florida and the potential in Texas.
"While rescheduling represents meaningful progress, there remains important work ahead to fully resolve the conflict between state and federal law and to advance broader criminal justice reforms," Vautrin added. "FLUENT remains committed to operating responsibly within the regulatory framework while supporting continued policy evolution that benefits patients, communities, and investors."
About FLUENT Corp.
FLUENT, a national cannabis consumer packaged goods company and retailer, is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by FLUENT's unrelenting commitment to operational excellence in cultivation, production, distribution, and retail experience. FLUENT produces an assortment of cannabis products under a diverse portfolio of brands including MOODS, Knack, Wandr, Bag-O and Hyer Kind. FLUENT operates in Florida, New York, Pennsylvania, and Texas. Headquartered in Tampa, Florida, FLUENT employs 700 employees across 8 cultivation and manufacturing facilities, 37 active retail locations and a wholesale division which trades under ENTOURAGE servicing third party retailers in New York. For more information on the Company's wholesale division ENTOURAGE, please visit https://entouragewholesale.com/-
FLUENT's Common Shares trade on the Canadian Securities Exchange under the symbol "FNT.U" and on the OTCQB Venture Market under the symbol "CNTMF". For more information about the Company, please visit www.getFLUENT.com-
Investor Relations Contact
investors@getFLUENT.com
Media Contact:
press@getFLUENT.com
Officer Contact:
Matt Mundy, Chief Legal Officer
(850) 972-8077
